hydrochlorothiazide has been researched along with fk 838 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gomi, T; Goto, A; Hirawa, N; Kaneko, H; Kawabata, Y; Nagoshi, H; Numabe, A; Omata, M; Toyo-oka, T; Uehara, Y | 1 |
Brooks, DP; Merz, E; Schnackenberg, CG | 1 |
2 other study(ies) available for hydrochlorothiazide and fk 838
Article | Year |
---|---|
A new adenosine subtype-1 receptor antagonist, FK-838, attenuates salt-induced hypertension in Dahl salt-sensitive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Creatinine; Eicosanoids; Hydrochlorothiazide; Hypertension; Kidney; Kidney Function Tests; Organ Size; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Rats; Rats, Inbred Strains; Sodium Chloride | 1995 |
An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
Topics: Adenosine A1 Receptor Antagonists; Administration, Oral; Animals; Chlorides; Diuresis; Diuretics; Dose-Response Relationship, Drug; Drug Synergism; Furosemide; Glomerular Filtration Rate; Hydrochlorothiazide; Male; Potassium; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Sodium | 2003 |